Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1977 Jan;11(1):84–87. doi: 10.1128/aac.11.1.84

Cefoxitin Activity Against Multiply Antibiotic-Resistant Klebsiella pneumoniae In Vitro

Roger T Jackson *, Frank E Thomas 1, Robert H Alford 1
PMCID: PMC351922  PMID: 319753

Abstract

Due to the emergence of cephalothin- and gentamicin-resistant Klebsiella pneumoniae at this institution, we investigated the in vitro activity of two new cephalosporin compounds—cefoxitin and cefamandole. Whereas both drugs were active against cephalothin- and gentamicin-susceptible isolates of Klebsiella, only cefoxitin exhibited significant activity against cephalothin- and gentamicin-resistant isolates. Seventeen of 20 (85%) of the cephalothin- and gentamicin-resistant isolates were inhibited by ≤12.5 μg of cefoxitin per ml. The minimum bactericidal concentration in broth of representative isolates equaled the agar dilution minimum inhibitory concentration. Kirby-Bauer disk susceptibility testing correlated well with the agar dilution minimum inhibitory concentration. Cephalothin and cefamandole resistance of isolates could be correlated with antibiotic degradation by β-lactamase. Cephalothin and cefamandole evoked only a transient decrease in viable bacterial cell count with rapid inactivation of antibiotics, and full regrowth of the organisms. Cefoxitin, on the other hand, was quite effective in vitro against multiply resistant Klebsiella. No β-lactamase degradation of cefoxitin was detected. Growth curves with antibiotics indicated rapid killing of cephalothin- and gentamicin-resistant isolates by cefoxitin.

Full text

PDF
84

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  2. Bodey G. P., Weaver S. In vitro studies of cefamandole. Antimicrob Agents Chemother. 1976 Mar;9(3):452–457. doi: 10.1128/aac.9.3.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Eykyn S., Jenkins C., King A., Phillips I. Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin. Antimicrob Agents Chemother. 1973 Jun;3(6):657–661. doi: 10.1128/aac.3.6.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Findell C. M., Sherris J. C. Susceptibility of Enterobacter to cefamandole: evidence for a high mutation rate to resistance. Antimicrob Agents Chemother. 1976 Jun;9(6):970–974. doi: 10.1128/aac.9.6.970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Goodwin C. S., Raftery E. B., Goldberg A. D., Skeggs H., Till A. E., Martin C. M. Effects of rate of infusion and probenecid on serum levels, renal excretion, and tolerance of intravenous doses of cefoxitin in humans: comparison with cephalothin. Antimicrob Agents Chemother. 1974 Sep;6(3):338–346. doi: 10.1128/aac.6.3.338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hoeprich P. D., Huston A. C. Induction of resistance in Staphylococcus aureus and Klebsiella pneumoniae by exposure to cephalothin and cefoxitin. J Infect Dis. 1976 Jun;133(6):681–685. doi: 10.1093/infdis/133.6.681. [DOI] [PubMed] [Google Scholar]
  7. Lewis R. P., Meyer R. D., Kraus L. L. Antibacterial activity of selected beta-lactam and aminoglycoside antibiotics against cephalothin-resistant Enterobacteriaceae. Antimicrob Agents Chemother. 1976 May;9(5):780–786. doi: 10.1128/aac.9.5.780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Onishi H. R., Daoust D. R., Zimmerman S. B., Hendlin D., Stapley E. O. Cefoxitin, a semisynthetic cephamycin antibiotic: resistance to beta-lactamase inactivation. Antimicrob Agents Chemother. 1974 Jan;5(1):38–48. doi: 10.1128/aac.5.1.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Rosen I. G., Jacobson J., Rudderman R. Rapid capillary tube method for detecting penicillin resistance in Staphylococcus aureus. Appl Microbiol. 1972 Mar;23(3):649–650. doi: 10.1128/am.23.3.649-650.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Schaberg D. R., Weinstein R. A., Stamm W. E. Epidemics of nosocomial urinary tract infection caused by multiply resistant gram-negative bacilli: epidemiology and control. J Infect Dis. 1976 Mar;133(3):363–366. doi: 10.1093/infdis/133.3.363. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES